Bioquark Inc. & Tissue Regeneration with Ira S. Pastor

Bioquark Inc. & Tissue Regeneration with Ira S. Pastor

Bioquark Inc. is focused on the development of novel biologics that have the ability to naturally modify the regulatory state of human tissues and organs, with the goal of curing a range of chronic degenerative diseases, as well as effecting complex regeneration.

The biologic regulatory states of our cells, tissues, and organs represent the central control processes behind our health (as well as our unfortunate transition towards disease, degeneration, and aging).

Merging 21st-century knowledge of regenerative biology, evolutionary genomics, and bio-cybernetics, Bioquark’s core program focuses on developing a novel class of substances termed combinatorial biologics, which take a unique approach to reversing underlying disease, degeneration or aging processes, as opposed to only affecting the symptoms of such conditions.

Ira Pastor, Chief Executive Officer

More than 30 years of experience across multiple sectors of the pharmaceutical industry including pharmaceutical commercialization, biotech drug development, managed care, distribution, OTC, and retail; Served as VP, Business Development for drug development company Phytomedics Inc., raising $40 million of private equity, consummating over $50 million of licensing deals, and bringing lead drug candidate from discovery stage to Phase III development.

For more information visit: http://www.bioquark.com/

*************************************************

For more information about BITEradio products and services visit: http://www.biteradio.me/index.htm